Biotech Startups

Science Care operates a non-transplant tissue banking program that partners with medical researchers and educators, enabling donor contributions for medical research, education, and product development. Founded in 2000, the organization manages donation programs while prioritizing donor dignity, ethical practices, and industry standards.

1 investor

Science Park provides project expertise in scientific-technical, technological, and marketing domains, and assists with preparing projects for financing and seed-stage syndicated investments.

1 investor

Scientist.com operates an online marketplace and platform for life science research, helping scientists find providers, scope projects, compare proposals, manage compliance, and track spend. The platform incorporates AI and expert support to coordinate outsourced research workflows across the research lifecycle for life science organizations.

1 investor

SCIEX develops mass spectrometry and capillary electrophoresis instruments, along with software and integrated workflows, for the precision detection and quantitation of molecules. Its products serve research scientists and clinical laboratories, including in vitro diagnostic applications.

1 investor

SciLeads provides a database and platform for identifying, engaging, and qualifying research scientists as sales prospects, serving B2B scientific companies globally with lead generation and market research capabilities.

1 investor

1 investor

SciLifeLab is a Swedish national research infrastructure organization that provides advanced technologies, expertise, and support services to life science researchers across Swedish universities. The organization operates ten national platforms offering various technologies and services through specialized units.

1 investor

SciNeuro develops targeted therapeutics for neurodegenerative and age-related brain diseases by integrating patient genetics, health history, and advanced diagnostic tools. The company collaborates with scientific institutions to create disease-modifying therapies addressing aging populations' neurological challenges.

1 investor

1 investor

ScionX develops xRNA, an engineered RNA platform that uses site-specific chemical modifications and expanded non-natural building blocks to extend protein expression from days to months and deliver multiple coordinated payloads against several disease drivers. It applies a deep-learning design engine and combinatorial chemical synthesis to build long-acting RNA therapeutics, initially focused on cardiometabolic and other chronic diseases.

1 investor

Sciphage develops phage-based products and operates a production facility in Colombia, positioning itself as a pioneer in bacteriophage applications within Latin America's industrial sector.

1 investor

SciRouter Vet is an AI-powered workspace focused on canine cancer, providing pet owners with educational answers backed by sources, clinical-trial alerts, journaling, and vet-sharing tools, and giving veterinarians handouts, a comparative oncology atlas, and case second-opinions. The company also develops AI to design custom mRNA vaccines from canine biopsies, targeting pet parents and veterinarians in the US.

1 investor

SciSafe provides biopharmaceutical storage, sample management, and cold chain logistics services for pharmaceutical companies, research institutes, and biotech firms across regulated temperature-controlled facilities. The company operates internationally with locations in New Jersey, Massachusetts, and the Netherlands, maintaining FDA, EU GDP, ISO, and CAP certifications.

1 investor

Scitara provides cloud-based integration and data management software for scientific laboratories, enabling connection of lab instruments and applications into a unified environment with AI-powered analytics. The platform serves life sciences companies and other science-based industries operating in regulated environments.

1 investor

Scitherm uses enzymatic synthesis to create novel structural variants with thermogenic activity, validated through channel affinity, in-vitro lipolysis, and in-vivo fat mass reduction studies. The company develops science-based thermal solutions aimed at metabolic health.

1 investor

Sciwind Biosciences is a commercial-stage biopharmaceutical company that discovers, develops, and delivers therapeutics focused on metabolic and weight management conditions, serving patients globally. It advances internal R&D programs and pursues out-licensing partnerships to bring treatments to market.

1 investor

Scopebio develops on-site molecular diagnostic assays for detecting crop pathogens, enabling rapid pathogen identification directly in the field. The company serves agricultural producers and offers custom assay development for emerging threats and niche crops.

1 investor

ScopeSys develops single-molecule imaging technology, called Convex Lens-induced Confinement (CLiC), that enables high-throughput measurements with single-molecule resolution for genomic-medicine drug development. Its platform helps developers of RNA, DNA, and nanoparticle-delivered drugs analyze single-molecule interactions to optimize therapeutic sequences and mRNA lipid nanoparticle formulations.

1 investor

Score Pharma is a biotech company developing biosuperior antibody therapeutics aimed at cancer treatment.

1 investor

ScotBio develops products through biotechnology, bringing together scientists and business staff to create offerings aimed at consumers and commercial partners. The page describes the team but provides limited detail on the specific products.

1 investor

1 investor

ScreenIn3D develops a lab-on-a-chip and 3D cell culture screening platform to accelerate drug discovery for pharmaceutical clients. The company is a University of Strathclyde spin-off based in Glasgow, UK.

1 investor

SD BIOSENSOR is a company involved in sustainable management and economic value creation, publishing an annual sustainability management report. The page content available describes only its sustainability reporting rather than its core products or services.

1 investor

Sea4Us develops marine-derived treatments and compounds targeting unmet clinical needs. The company conducts research and development on marine organisms and their bioactive properties for pharmaceutical and healthcare applications.

1 investor